Skip to main content

Mireia Salvadó Pau

Institutions of which they are part

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Mireia Salvadó Pau

Institutions of which they are part

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Projects

Creación de un método de referencia para detectar Apo-lb por espectrometría de masas dirigida y validación clínica de su potencial como biomarcadore para el síndrome nefrótico idiopático

IP: Concepció Jacobs Cachá
Collaborators: Yolanda Villena Ortiz, Joan López Hellin, Mireia Salvadó Pau, Carmen Llorens Cebriá
Funding agency: Instituto de Salud Carlos III
Funding: 71250
Reference: PI24/01573
Duration: 01/01/2025 - 31/12/2027

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The new system, made of cellulose and chitosan, enables sustained release of docetaxel and has demonstrated antitumor activity in preclinical models of ovarian cancer and glioblastoma.

Related professionals

Alejandro Solis Peña

Alejandro Solis Peña

Main researcher
General Surgery
Read more
Enzamaría Fidilio Meli

Enzamaría Fidilio Meli

Predoctoral researcher
Read more
Maria Francesca Cortese

Maria Francesca Cortese

Main researcher
Microbiology
Read more
Maria Victoria Gonzalez Martinez

Maria Victoria Gonzalez Martinez

Senior researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.